Beta Bionics, Inc. (BBNX) stock
BBNXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 11/3010% below fair value
$13.36+0.04 (+0.30%)
Close on Nov 20, 2026Market cap $726.34MP/E –Yield –
Beta Bionics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Beta Bionics's gross profit for the twelve months ending Sep 30, 2026 was $74.61M, up 54.5% year over year. For fiscal 2025 it was $55.54M, up 54.8% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.54M | +54.8% |
| FY2024 | Dec 31, 2024 | $35.89M | +468.9% |
| FY2023 | Dec 31, 2023 | $6.31M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $20.33M | +34.5% |
| Q2 FY2026 | Jun 30, 2026 | $18.90M | +51.2% |
| Q1 FY2026 | Mar 31, 2026 | $16.44M | +83.2% |
| Q4 FY2025 | Dec 31, 2025 | $18.94M | +62.1% |
| Q3 FY2025 | Sep 30, 2025 | $15.12M | +69.6% |
| Q2 FY2025 | Jun 30, 2025 | $12.50M | +54.7% |
| Q1 FY2025 | Mar 31, 2025 | $8.97M | +24.6% |
| Q4 FY2024 | Dec 31, 2024 | $11.69M | – |
| Q3 FY2024 | Sep 30, 2024 | $8.91M | – |
| Q2 FY2024 | Jun 30, 2024 | $8.08M | – |
| Q1 FY2024 | Mar 31, 2024 | $7.20M | – |
See a number that looks wrong?